Group issues statement explaining shareholding structure
A health worker holds a syringe and a vial of the Sinovac coronavirus disease vaccine at a market after hundreds of local residents in the district tested positive in Bangkok on March 17 this year. (Reuters photo)
The Charoen Pokphand group says it has nothing to do with the purchases of the Covid-19 vaccine made by Sinovac Biotech by the Thai government.
In a rare response to the public, the multinational group controlled by Dhanin Chearavanont, Thailand’s richest man with net worth of $18.1 billion on the 2021 Forbes list, issued a statement on Tuesday, giving details on its link with the Chinese vaccine manufacturer.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.